TrumpRx? Pfizer, Drugmakers AGREE To LOWER Drug Prices For MEDICAID Recipients | TRENDING

President Trump on Tuesday announced that Pfizer had agreed to sell its products in the U.S. at “Most Favored Nation” pricing, one day after the administration required companies to respond to his prescription drug pricing executive order.

Drugmakers were given until Sept. 29 to respond to Trump’s “Most Favored Nation” Executive Order that required companies sell drugs in the U.S. at the lowest price they sell in other developed countries, establish direct-to-consumer avenues and not sell new drugs for lower prices in other countries.

“Pfizer is committing to offer all of their prescription medications to Medicaid. it will be at the most favored nation’s prices. It’s going to have a huge impact on bringing Medicaid costs down like nothing else,” Trump said in a press briefing in the Oval Office.

Trump had sent requests to 16 other drugmakers in his executive order. It’s unclear if others will follow Pfizer’s lead. Some of the companies told The Hill on Monday they remained in discussions with the administration.